MEDICAL DICTIONARY
Estrogen replacement therapy (ERT): Estrogen replacement therapy (ERT) is used to treat menopause . It reduces or stops the short-term changes of menopause such as hot flashes, disturbed sleep , and vaginal dryness. ERT can prevent osteoporosis , a consequence of lowered estrogen levels. To keep bones strong, ERT should be taken from menopause throughout a woman's life. Stopping ERT allows bone loss to resume.
ERT reduces the risk of heart disease up to 50%. Vaginal ERT products help with vaginal dryness, more severe vaginal changes, and bladder effects but, since very little vaginal estrogen enters the circulation, it may not help with hot flashes or prevent osteoporosis and heart disease.
The use of unopposed ERT (ERT alone) is associated with an increase in the risk of endometrial cancer (cancer of the lining of the uterus). However, by taking the hormone progestogen along with estrogen, the risk of endometrial cancer is reduced substantially. Progestogen protects the uterus by keeping the endometrium from thickening (an effect caused by estrogen). The combination therapy of estrogen plus progestogen is called hormone replacement therapy (HRT).
|
DISCLAIMER:
Information on this site is provided for informational
purposes and is not meant to substitute for the advice
provided by your own physician or other medical professional.
You should not use the information contained herein
for diagnosing or treating a health problem or disease,
or prescribing any medication. You should read carefully
all product packaging. Not all Canadian drugs, Canada
prescription and Canadian prescription medicine is available
at discount Canadian on line pharmacies. If you have
or suspect that you have a medical problem, promptly
contact your health care provider. Information and statements
regarding diet supplements have not been evaluated by
Health Canada and are not intended to diagnose, treat,
cure, or prevent any disease. All trade and service
marks mentioned on this site are recognized as belonging
to their respective owners.
|
|
|
|
